Federated Hermes’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Federated Hermes’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-327,430	Closed	-$10.9M	–	2407
2020 Q2	$10.9M	Buy	327,430 +100,042	+44%	+$3.19M	0.03%	524
2020 Q1	$6.18M	Buy	+227,388	New	+$6.33M	0.02%	581
2019 Q4	–	Sell	-4,396	Closed	-$57K	–	2353
2019 Q3	$57K	Buy	4,396 +336	+8%	+$4.06K	﹤0.01%	1713
2019 Q2	$51K	Sell	4,060 -913	-18%	-$12.1K	﹤0.01%	1675
2019 Q1	$72K	Sell	4,973 -452	-8%	-$5.77K	﹤0.01%	1624
2018 Q4	$60K	Buy	+5,425	New	+$75.5K	﹤0.01%	1649
2017 Q2	–	Sell	-50,543	Closed	-$675K	–	2213
2017 Q1	$675K	Buy	+50,543	New	+$792K	﹤0.01%	1269

Other funds holding MNTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

Federated Hermes's MNTA Position: Q3 2020 in Review

Federated Hermes sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 327,430 shares — an estimated $10.9M sold.

Federated Hermes first reported a position in MNTA in Q1 2017 and held it in 7 quarters. The position peaked at $10.9M in Q2 2020. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.

Federated Hermes reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Federated Hermes sold 327,430 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $10.9M.
Federated Hermes first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2017 and held it in 7 quarters.
Federated Hermes's Momenta Pharmaceuticals, Inc. position peaked at $10.9M in Q2 2020.
211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.

Based on Federated Hermes's 13F filing for Q3 2020, filed 12 Nov 2020.